Quercetin with Bromelain (Zelenco "Covid 19" Protocol)
Posted: Sat Jan 29, 2022 2:59 pm
I would highly recommend everyone to pick up some of this and have some extra on hand this is a generic form of hydroxychloroquine (HCQ). People are buying this in droves at the health food stores. Take two capsules 20 minutes before dinner two times a day.
Quercetin and zinc are part of the FLCCC and Zelenko protocols for the prevention and early treatment of COVID-19. Quercetin was initially found to provide broad-spectrum protection against SARS coronavirus in the aftermath of the SARS epidemic that broke out across 26 countries in 2003. Quercetin has also been found to have antiviral activity in Influenza A, Ebola and Zika viruses. Now, some doctors are advocating its use against SARS-CoV-2, in combination with vitamin C, noting that the two have synergistic effects.
Quercetin acts as a zinc ionophore (PubMed 2014), the same mechanism of action that hydroxychloroquine has via helping zinc pass the cell wall where it might halt viral replication.
This zinc ionophore activity of quercetin facilitates the transport of zinc across the cell membrane. It is known that zinc will slow down the replication of coronavirus through inhibition of enzyme RNA polymerase (PubMed 2010). The COVID-19 is an RNA (RiboNucleicAcid) virus and requires the RNA polymerase to replicate. Do take note that the study publication was a 2010 publication and is referring to a different coronavirus as compared to the latest coronavirus (COVID-19); though both are from the same family of coronaviruses.
Quercetin and Vitamin C
Incidentally, ascorbic acid (vitamin C) and the bioflavonoid quercetin (originally labeled vitamin P) were both discovered by the same scientist — Nobel prize winner Albert Szent-Györgyi. Quercetin and vitamin C also act as an antiviral drug, effectively inactivating viruses.
The initial MATH+ protocol was released in April 2020. In early July and August, it was updated to include quercetin and a number of optional nutrients and drugs, not only for critical care but also for prophylaxis and mild disease being treated at home.
There is evidence that vitamin C and quercetin co-administration exerts a synergistic antiviral action due to overlapping antiviral and immunomodulatory properties and the capacity of ascorbate to recycle quercetin, increasing its efficacy.
Quercetin, zinc, vitamin D, C and melatonin and part of the latest FLCCC I-MASK+ protocol. For updated prevention and early outpatient protocol (COVID-19 positive), please check out FLCCC I-MASK+ protocol.
The Association of American Physicians and Surgeons recommends the following outpatient treatment protocol for COVID-19 (Zelenko Protocol):
Quercetin oral 500 mg twice a day.
Vitamin C 3000 mg
Vitamin D3 5000 IU
Zinc sulphate 220 mg
Also:
Sweet Wormwood & Black Walnut
Quercetin with Bromelain
https://www.iherb.com/pr/now-foods-quer ... ules/18416
Vitimin C 1000 IU
https://www.iherb.com/pr/now-foods-c-10 ... ablets/466
Vitimin D3 5000 IU
https://www.iherb.com/pr/now-foods-vita ... gels/22335
Zinc
https://www.iherb.com/pr/now-foods-zinc ... ablets/883
Black Walnut Wormwood
https://www.iherb.com/pr/now-foods-gree ... -59-ml/591
-
Early Research Finds Extracts from Sweet Wormwood Plant Can Inhibit the COVID-19 Virus
Laboratory Findings Suggest Artemisia annua, also known as sweet wormwood May Point to Treatment for SARS-CoV-2
A team of researchers that includes Worcester Polytechnic Institute Biology Professor Pamela Weathers has found that extracts from the leaves of the Artemisia annua plant, a medicinal herb also known as sweet wormwood, inhibit the replication of the SARS-CoV-2 virus and two of its recent variants.
The team, which included researchers from Columbia University in New York and the University of Washington at Seattle, also found that extracts of the plant were more effective against the virus when levels of a key therapeutic compound in the plant, artemisinin, were low. The in vitro findings led the researchers to suggest that one or more compounds in Artemisia annua, or A. annua, that have not yet been identified may point to a safe, low-cost therapeutic treatment for SARS-CoV-2, the virus responsible for the COVID-19 pandemic.
“Artemisia annua has been studied extensively, and it has been used safely for more than 2,000 years in traditional medicine to treat a variety of fever-related ailments,” Weathers said. “A. annua could provide clues to new safe, cost-effective small molecule therapies or even be used as an antiviral nutraceutical.”
The researchers soaked dried leaves of A. annua, obtained from four continents in hot water and tested the solutions against SARS-CoV-2 and two variants originating from the United Kingdom and South Africa. Some leaf samples were 12 years old but still potent against the virus. Researchers also tested artemisinin alone against the viruses, but the plant extracts were more potent. Artemisinin is a compound naturally produced by the plant, but is usually extracted, chemically modified, and developed in combination with other drugs to treat malaria.
Results showed that the extracts of A. annua did not block the virus from entering cells but interfered with the virus’ ability to replicate, thus killing it. In addition, the anti-replication activity did not appear linked to artemisinin or flavonoids, which are natural substances in the plants.
Weathers has long studied different strains of Artemisia, which are grown around the world. She recently was a co-author on papers exploring the anti-malaria properties of artemisinin and the impact of A. annua and artemisinin extracts on the malaria parasite. She also is collaborating on a study at WPI to identify compounds in A. annua that may be effective against the bacteria responsible for tuberculosis.
Weathers said more work is needed to identify the compound or combination of compounds in A. annua responsible for inhibiting viral replication.
“These findings add to evidence emerging from other labs around the world that this plant possesses compounds that could help patients who are infected with COVID-19,” Weathers said. “We also know that the plant possesses compounds that inhibit inflammation and the formation of scar-like tissues known as fibrosis, which also affect patients with COVID-19. Together, these characteristics point to a plant that bears a lot more study.”